397 related articles for article (PubMed ID: 9263354)
1. Aspirin in essential thrombocythemia: status quo and quo vadis.
Griesshammer M; Bangerter M; van Vliet HH; Michiels JJ
Semin Thromb Hemost; 1997; 23(4):371-7. PubMed ID: 9263354
[TBL] [Abstract][Full Text] [Related]
2. Aspirin for the control of platelet activation and prevention of thrombosis in essential thrombocythemia and polycythemia vera: current insights and rationale for future studies.
Landolfi R; Di Gennaro L; Novarese L; Patrono C
Semin Thromb Hemost; 2006 Apr; 32(3):251-9. PubMed ID: 16673279
[TBL] [Abstract][Full Text] [Related]
3. The paradox of bleeding and thrombosis in thrombocythemia: is von Willebrand factor the link?
van Genderen PJ; Leenknegt H; Michiels JJ
Semin Thromb Hemost; 1997; 23(4):385-9. PubMed ID: 9263356
[TBL] [Abstract][Full Text] [Related]
4. Neurologic and visual symptoms in essential thrombocythemia: efficacy of low-dose aspirin.
Koudstaal PJ; Koudstaal A
Semin Thromb Hemost; 1997; 23(4):365-70. PubMed ID: 9263353
[TBL] [Abstract][Full Text] [Related]
5. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
[TBL] [Abstract][Full Text] [Related]
6. Aspirin in polycythemia vera and essential thrombocythemia: current facts and perspectives.
Landolfi R; Patrono C
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():83-6. PubMed ID: 8951777
[TBL] [Abstract][Full Text] [Related]
7. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
[TBL] [Abstract][Full Text] [Related]
8. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
[TBL] [Abstract][Full Text] [Related]
9. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
[TBL] [Abstract][Full Text] [Related]
10. Acquired thrombophilia in pregnancy: essential thrombocythemia.
Griesshammer M; Grünewald M; Michiels JJ
Semin Thromb Hemost; 2003 Apr; 29(2):205-12. PubMed ID: 12709924
[TBL] [Abstract][Full Text] [Related]
11. Thrombosis and bleeding in polycythemia vera and essential thrombocythemia: pathogenetic mechanisms and prevention.
Landolfi R; Cipriani MC; Novarese L
Best Pract Res Clin Haematol; 2006; 19(3):617-33. PubMed ID: 16781491
[TBL] [Abstract][Full Text] [Related]
12. Platelet-mediated microvascular inflammation and thrombosis in thrombocythemia vera: a distinct aspirin-responsive arterial thrombophilia, which transforms into a bleeding diathesis at increasing platelet counts.
Michiels JJ
Pathol Biol (Paris); 2003 Apr; 51(3):167-75. PubMed ID: 12781799
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of bleeding and thrombosis in myeloproliferative disorders.
Landolfi R; Marchioli R; Patrono C
Thromb Haemost; 1997 Jul; 78(1):617-21. PubMed ID: 9198226
[TBL] [Abstract][Full Text] [Related]
14. Pericardial hemorrhage due to acetylsalicylic acid in a patient with essential thrombocythemia.
Kayrak M; Acar K; Yazici M; Kaya C; Ayhan SS; Gok H
Clin Appl Thromb Hemost; 2009; 15(4):465-6. PubMed ID: 18160579
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of 386 consecutive patients with essential thrombocythemia: safety of cytoreductive therapy.
Palandri F; Catani L; Testoni N; Ottaviani E; Polverelli N; Fiacchini M; De Vivo A; Salmi F; Lucchesi A; Baccarani M; Vianelli N
Am J Hematol; 2009 Apr; 84(4):215-20. PubMed ID: 19208420
[TBL] [Abstract][Full Text] [Related]
16. Treatment indications and choice of a platelet-lowering agent in essential thrombocythemia.
Barbui T; Finazzi G
Curr Hematol Rep; 2003 May; 2(3):248-56. PubMed ID: 12901347
[TBL] [Abstract][Full Text] [Related]
17. Platelet-mediated thrombotic complications in patients with ET: Reversal by aspirin, platelet reduction, and not by coumadin.
Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; van Vliet HH
Blood Cells Mol Dis; 2006; 36(2):199-205. PubMed ID: 16510297
[TBL] [Abstract][Full Text] [Related]
18. Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders.
Wehmeier A; Südhoff T; Meierkord F
Semin Thromb Hemost; 1997; 23(4):391-402. PubMed ID: 9263357
[TBL] [Abstract][Full Text] [Related]
19. Aspirin-responsive, migraine-like transient cerebral and ocular ischemic attacks and erythromelalgia in JAK2-positive essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Gadisseur A; Lam KH; De Raeve H; Schroyens W
Acta Haematol; 2015; 133(1):56-63. PubMed ID: 25116182
[TBL] [Abstract][Full Text] [Related]
20. Platelet consumption in thrombocythemia complicated by erythromelalgia: reversal by aspirin.
van Genderen PJ; Michiels JJ; van Strik R; Lindemans J; van Vliet HH
Thromb Haemost; 1995 Feb; 73(2):210-4. PubMed ID: 7792731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
